CRM197 Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global CRM197 market size was valued at USD 177.2 million in 2022 and is forecast to a readjusted size of USD 249.9 million by 2029 with a CAGR of 5.0% during review period.

CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.

Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.

This report is a detailed and comprehensive analysis for global CRM197 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global CRM197 market size and forecasts, in consumption value ($ Million), 2018-2029
Global CRM197 market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global CRM197 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global CRM197 market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRM197
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global CRM197 market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Pfizer Inc.
   Ligand Pharmaceuticals
   CanSino Biologic
   Beijing Kexing Biology Product
   Scarab Genomics
   Xpress Biologics
   Fina Biosolutions
   Eubiologics
   EirGenix Inc.

   Research Grade CRM197
   cGMP Grade CRM197

   Pneumococcal Conjugate Vaccine
   Meningococcal Polysaccharide Conjugate Vaccine
   Others

   North America (United States, Canada, and Mexico)
   Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
   South America (Brazil, Argentina and Rest of South America)
   Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

What are the strengths of the CRM197 market in 2025?

CRM197’s key strength lies in its potential as a non-toxic carrier protein for vaccines. It enhances the immunogenicity of conjugate vaccines, making it a crucial component for both developed and emerging markets. Additionally, its application in developing vaccines for rare diseases presents significant opportunities for growth.

What are the weaknesses of the CRM197 market in 2025?

One weakness is the high cost of production and development, which can hinder market growth, especially in low-income regions. Furthermore, its use in certain vaccine formulations is still being researched, so market adoption might be slow due to uncertainties about long-term efficacy and safety.

What are the opportunities in the CRM197 market in 2025?

As the global demand for vaccines rises, particularly in response to emerging infectious diseases and pandemics, CRM197's role in vaccine development presents a major opportunity. The market for rare disease treatments is also expanding, providing CRM197 a niche to address unmet medical needs.

What are the threats to the CRM197 market in 2025?

Competition from alternative vaccine carrier proteins and advancements in other vaccine technologies could pose a threat to CRM197's market share. Regulatory hurdles and changes in healthcare policy might also impact the pace at which CRM197-based vaccines are brought to market.

What are the political factors affecting the CRM197 market in 2025?

Political factors such as government healthcare spending and vaccine regulations will significantly impact the CRM197 market. Governments' focus on public health and their support for vaccine development can either foster growth or create challenges depending on the prioritization of certain diseases and vaccine platforms.

How do economic factors influence the CRM197 market in 2025?

Economic factors like healthcare budgets and the cost of developing and producing CRM197-based vaccines will play a key role. While there’s an increasing global demand for vaccines, the high cost of CRM197’s production could limit access in low-income regions, impacting overall market expansion.

What are the social factors affecting the CRM197 market in 2025?

Social factors such as rising awareness of vaccine safety and the increasing demand for vaccines in developing countries will influence the CRM197 market. Public trust in vaccines and awareness campaigns around vaccine-preventable diseases can drive CRM197's adoption, but vaccine hesitancy might limit growth in some regions.

What are the technological factors affecting the CRM197 market in 2025?

Technological advancements in biotechnology and vaccine production processes will be crucial for CRM197’s market growth. New developments in protein engineering, manufacturing techniques, and adjuvants could improve the efficiency and cost-effectiveness of CRM197-based vaccines, enabling broader market penetration.

What are the environmental factors influencing the CRM197 market in 2025?

Environmental factors, such as the impact of climate change on disease patterns, could increase the demand for vaccines, including CRM197-based ones. Additionally, sustainability concerns in the vaccine production process could prompt innovations in green manufacturing methods for CRM197.

What are the legal factors affecting the CRM197 market in 2025?

Legal factors, including intellectual property rights, patent expirations, and regulatory approvals, will be key to CRM197’s market dynamics. Strict vaccine regulations and approval processes could delay market entry, while potential changes in patent laws could lead to increased competition from generic vaccine manufacturers.

Who are the suppliers in the CRM197 market in 2025?

Suppliers include biotech and pharmaceutical companies that produce the raw materials for CRM197, such as the protein itself and other necessary components for vaccine formulations. These suppliers also include manufacturers of specialized equipment for protein purification and vaccine production.

What are the inputs for the CRM197 market in 2025?

Inputs involve the raw materials for CRM197 production, including recombinant DNA technology, microbial culture systems, and specialized equipment for protein synthesis. Research and development activities, as well as regulatory frameworks, also serve as critical inputs in the production and approval of CRM197-based vaccines.

What are the processes in the CRM197 market in 2025?

Processes include the production of CRM197 through biotechnological methods, its integration into conjugate vaccine formulations, clinical trials to ensure efficacy and safety, regulatory approval processes, and large-scale manufacturing of vaccines for distribution.

Who are the customers in the CRM197 market in 2025?

Customers primarily include pharmaceutical companies that use CRM197 in vaccine development, healthcare providers that administer vaccines, and governments or health organizations that purchase vaccines for public health programs. Additionally, emerging markets with rising healthcare needs represent significant customers.

What are the outputs of the CRM197 market in 2025?

Outputs include CRM197-based vaccines that are designed to prevent various infectious diseases. These vaccines are distributed to healthcare providers, governments, and NGOs for mass immunization programs, contributing to disease prevention efforts worldwide.

What is the threat of new entrants in the CRM197 market in 2025?

The threat of new entrants is moderate. While the biotechnology and pharmaceutical industries have a high barrier to entry due to the complex and costly nature of vaccine development, new players with innovative technologies or access to cheaper production methods could still enter the market.

What is the bargaining power of suppliers in the CRM197 market in 2025?

The bargaining power of suppliers is moderate to high. CRM197’s production depends on specialized raw materials and sophisticated technology, which are primarily provided by a few large suppliers. This concentration gives suppliers more power to influence prices and availability.

What is the bargaining power of buyers in the CRM197 market in 2025?

The bargaining power of buyers is relatively low. As CRM197 is a critical component in vaccines with limited alternatives, buyers such as pharmaceutical companies and government health agencies have less power to negotiate prices, especially in the face of rising global vaccine demand.

What is the threat of substitute products in the CRM197 market in 2025?

The threat of substitutes is moderate. While there are alternative carrier proteins and vaccine technologies, CRM197’s established use in conjugate vaccines and its proven effectiveness keeps it competitive. However, advancements in vaccine technology could eventually lead to substitutes emerging.

What is the intensity of competitive rivalry in the CRM197 market in 2025?

The intensity of competitive rivalry is moderate. Several pharmaceutical and biotechnology companies are engaged in CRM197-based vaccine development, but the market is still somewhat niche, limiting competition. However, innovation and patents are critical drivers, making the competitive environment dynamic.

What are the key suppliers in the CRM197 market in 2025?

Key suppliers include biotechnology companies that provide recombinant DNA technology and manufacturing capabilities for CRM197 production. Additionally, suppliers of microbial culture systems, purification equipment, and raw materials essential for the production of conjugate vaccines play a critical role in the upstream process.

What are the major inputs required in the CRM197 market in 2025?

The major inputs include the genetic material needed to produce CRM197, specialized bioreactors for microbial cultivation, proteins, adjuvants, and other chemical reagents necessary for the conjugation process. Advanced research and development efforts are also vital inputs to improve CRM197’s efficacy and manufacturing scalability.

What are the challenges faced in the upstream process of CRM197 production?

Challenges include the high cost of manufacturing and scalability issues, as producing CRM197 requires sophisticated biotechnology processes. Additionally, ensuring consistent quality and yield from microbial cultures can be difficult. Regulatory requirements for biotechnological products also present significant challenges in this upstream process.

What are the technological advancements influencing upstream activities in the CRM197 market?

Technological advancements in gene editing, protein engineering, and fermentation technology are critical in improving the yield and cost-effectiveness of CRM197 production. Innovations in automated bioreactors and purification processes also help streamline production, reducing costs and increasing consistency.

What role do regulatory factors play in the upstream CRM197 market in 2025?

Regulatory factors significantly affect the upstream process, as CRM197 is a key component in vaccines that must meet stringent safety, quality, and efficacy standards. Compliance with global health authorities’ regulations, such as the FDA and EMA, is crucial for the approval of CRM197-based vaccines and for scaling up production.

What are the key processes in the midstream CRM197 market in 2025?

Key processes include the formulation of CRM197-based conjugate vaccines, which involves conjugating CRM197 with polysaccharides to enhance its immunogenicity. Other processes include quality control, clinical trials for efficacy and safety, and regulatory submissions to health authorities for vaccine approval.

What role do manufacturers play in the midstream CRM197 market?

Manufacturers play a central role in producing CRM197-based vaccines at scale. They handle the bulk production of the vaccine, ensuring consistency and adherence to Good Manufacturing Practices (GMP). They also manage packaging, labeling, and distribution to meet the demands of healthcare providers and governments.

What challenges are faced in the midstream CRM197 market?

Challenges include maintaining consistent quality and scale during vaccine production, meeting regulatory requirements across different regions, and managing costs associated with the sophisticated nature of CRM197-based vaccine development. Additionally, logistical issues around global distribution and storage can complicate the process.

What technological advancements are shaping the midstream CRM197 market?

Advancements in automated vaccine production systems, improved conjugation techniques, and faster, more efficient clinical trial designs are key to enhancing midstream activities. Technologies like cold chain logistics are also improving, ensuring CRM197-based vaccines are effectively distributed and stored globally.

What is the importance of regulatory approval in the midstream CRM197 market?

Regulatory approval is crucial in the midstream market, as vaccines must meet rigorous safety, quality, and efficacy standards set by health authorities such as the FDA and EMA. Successful approval is needed before CRM197-based vaccines can be marketed and distributed for widespread use.

What are the key activities in the downstream CRM197 market in 2025?

Key activities include the distribution of CRM197-based vaccines to healthcare providers, government agencies, and international organizations. This stage also involves marketing, post-market surveillance, and monitoring vaccine performance through real-world data to ensure continued safety and efficacy.

What are the primary distribution channels in the downstream CRM197 market?

Primary distribution channels include government health programs, international organizations like the WHO, and private healthcare providers. Vaccines are distributed through a network of wholesalers, logistics companies, and cold chain systems to ensure the vaccines are delivered in optimal conditions to global markets.

What challenges are faced in the downstream CRM197 market?

Challenges include ensuring equitable access to CRM197-based vaccines in low-income regions, managing the complexities of global distribution, and addressing logistical challenges like cold chain management. Additionally, the market faces hurdles related to vaccine hesitancy and varying regulatory approvals across different countries.

What role do healthcare providers play in the downstream CRM197 market?

Healthcare providers are crucial in administering CRM197-based vaccines to the population. Their role involves educating patients, ensuring proper vaccination schedules, and reporting adverse events for post-market surveillance. They are also key partners in the ongoing monitoring of vaccine safety and effectiveness.

What are the key trends in the downstream CRM197 market?

Key trends include an increased focus on vaccine accessibility and affordability, particularly in emerging markets, and the growing role of digital tools for monitoring vaccination coverage and efficacy. There is also a shift towards public-private partnerships to address global vaccination needs and challenges.

Chapter 1, to describe CRM197 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRM197, with revenue, gross margin and global market share of CRM197 from 2018 to 2023.
Chapter 3, the CRM197 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and CRM197 market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of CRM197.
Chapter 13, to describe CRM197 research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of CRM197
   1.2 Market Estimation Caveats and Base Year
   1.3 Classification of CRM197 by Type
       1.3.1 Overview: Global CRM197 Market Size by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Global CRM197 Consumption Value Market Share by Type in 2022
       1.3.3 Research Grade CRM197
       1.3.4 cGMP Grade CRM197
   1.4 Global CRM197 Market by Application
       1.4.1 Overview: Global CRM197 Market Size by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Pneumococcal Conjugate Vaccine
       1.4.3 Meningococcal Polysaccharide Conjugate Vaccine
       1.4.4 Others
   1.5 Global CRM197 Market Size & Forecast
   1.6 Global CRM197 Market Size and Forecast by Region
       1.6.1 Global CRM197 Market Size by Region: 2018 VS 2022 VS 2029
       1.6.2 Global CRM197 Market Size by Region, (2018-2029)
       1.6.3 North America CRM197 Market Size and Prospect (2018-2029)
       1.6.4 Europe CRM197 Market Size and Prospect (2018-2029)
       1.6.5 Asia-Pacific CRM197 Market Size and Prospect (2018-2029)
       1.6.6 South America CRM197 Market Size and Prospect (2018-2029)
       1.6.7 Middle East and Africa CRM197 Market Size and Prospect (2018-2029)

2 Company Profiles

   2.1 Pfizer Inc.
       2.1.1 Pfizer Inc. Details
       2.1.2 Pfizer Inc. Major Business
       2.1.3 Pfizer Inc. CRM197 Product and Solutions
       2.1.4 Pfizer Inc. CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Pfizer Inc. Recent Developments and Future Plans
   2.2 Ligand Pharmaceuticals
       2.2.1 Ligand Pharmaceuticals Details
       2.2.2 Ligand Pharmaceuticals Major Business
       2.2.3 Ligand Pharmaceuticals CRM197 Product and Solutions
       2.2.4 Ligand Pharmaceuticals CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Ligand Pharmaceuticals Recent Developments and Future Plans
   2.3 CanSino Biologic
       2.3.1 CanSino Biologic Details
       2.3.2 CanSino Biologic Major Business
       2.3.3 CanSino Biologic CRM197 Product and Solutions
       2.3.4 CanSino Biologic CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 CanSino Biologic Recent Developments and Future Plans
   2.4 Beijing Kexing Biology Product
       2.4.1 Beijing Kexing Biology Product Details
       2.4.2 Beijing Kexing Biology Product Major Business
       2.4.3 Beijing Kexing Biology Product CRM197 Product and Solutions
       2.4.4 Beijing Kexing Biology Product CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Beijing Kexing Biology Product Recent Developments and Future Plans
   2.5 Scarab Genomics
       2.5.1 Scarab Genomics Details
       2.5.2 Scarab Genomics Major Business
       2.5.3 Scarab Genomics CRM197 Product and Solutions
       2.5.4 Scarab Genomics CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Scarab Genomics Recent Developments and Future Plans
   2.6 Xpress Biologics
       2.6.1 Xpress Biologics Details
       2.6.2 Xpress Biologics Major Business
       2.6.3 Xpress Biologics CRM197 Product and Solutions
       2.6.4 Xpress Biologics CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Xpress Biologics Recent Developments and Future Plans
   2.7 Fina Biosolutions
       2.7.1 Fina Biosolutions Details
       2.7.2 Fina Biosolutions Major Business
       2.7.3 Fina Biosolutions CRM197 Product and Solutions
       2.7.4 Fina Biosolutions CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Fina Biosolutions Recent Developments and Future Plans
   2.8 Eubiologics
       2.8.1 Eubiologics Details
       2.8.2 Eubiologics Major Business
       2.8.3 Eubiologics CRM197 Product and Solutions
       2.8.4 Eubiologics CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Eubiologics Recent Developments and Future Plans
   2.9 EirGenix Inc.
       2.9.1 EirGenix Inc. Details
       2.9.2 EirGenix Inc. Major Business
       2.9.3 EirGenix Inc. CRM197 Product and Solutions
       2.9.4 EirGenix Inc. CRM197 Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 EirGenix Inc. Recent Developments and Future Plans

3 Market Competition, by Players

   3.1 Global CRM197 Revenue and Share by Players (2018-2023)
   3.2 Market Share Analysis (2022)
       3.2.1 Market Share of CRM197 by Company Revenue
       3.2.2 Top 3 CRM197 Players Market Share in 2022
       3.2.3 Top 6 CRM197 Players Market Share in 2022
   3.3 CRM197 Market: Overall Company Footprint Analysis
       3.3.1 CRM197 Market: Region Footprint
       3.3.2 CRM197 Market: Company Product Type Footprint
       3.3.3 CRM197 Market: Company Product Application Footprint
   3.4 New Market Entrants and Barriers to Market Entry
   3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

   4.1 Global CRM197 Consumption Value and Market Share by Type (2018-2023)
   4.2 Global CRM197 Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

   5.1 Global CRM197 Consumption Value Market Share by Application (2018-2023)
   5.2 Global CRM197 Market Forecast by Application (2024-2029)

6 North America

   6.1 North America CRM197 Consumption Value by Type (2018-2029)
   6.2 North America CRM197 Consumption Value by Application (2018-2029)
   6.3 North America CRM197 Market Size by Country
       6.3.1 North America CRM197 Consumption Value by Country (2018-2029)
       6.3.2 United States CRM197 Market Size and Forecast (2018-2029)
       6.3.3 Canada CRM197 Market Size and Forecast (2018-2029)
       6.3.4 Mexico CRM197 Market Size and Forecast (2018-2029)

7 Europe

   7.1 Europe CRM197 Consumption Value by Type (2018-2029)
   7.2 Europe CRM197 Consumption Value by Application (2018-2029)
   7.3 Europe CRM197 Market Size by Country
       7.3.1 Europe CRM197 Consumption Value by Country (2018-2029)
       7.3.2 Germany CRM197 Market Size and Forecast (2018-2029)
       7.3.3 France CRM197 Market Size and Forecast (2018-2029)
       7.3.4 United Kingdom CRM197 Market Size and Forecast (2018-2029)
       7.3.5 Russia CRM197 Market Size and Forecast (2018-2029)
       7.3.6 Italy CRM197 Market Size and Forecast (2018-2029)

8 Asia-Pacific

   8.1 Asia-Pacific CRM197 Consumption Value by Type (2018-2029)
   8.2 Asia-Pacific CRM197 Consumption Value by Application (2018-2029)
   8.3 Asia-Pacific CRM197 Market Size by Region
       8.3.1 Asia-Pacific CRM197 Consumption Value by Region (2018-2029)
       8.3.2 China CRM197 Market Size and Forecast (2018-2029)
       8.3.3 Japan CRM197 Market Size and Forecast (2018-2029)
       8.3.4 South Korea CRM197 Market Size and Forecast (2018-2029)
       8.3.5 India CRM197 Market Size and Forecast (2018-2029)
       8.3.6 Southeast Asia CRM197 Market Size and Forecast (2018-2029)
       8.3.7 Australia CRM197 Market Size and Forecast (2018-2029)

9 South America

   9.1 South America CRM197 Consumption Value by Type (2018-2029)
   9.2 South America CRM197 Consumption Value by Application (2018-2029)
   9.3 South America CRM197 Market Size by Country
       9.3.1 South America CRM197 Consumption Value by Country (2018-2029)
       9.3.2 Brazil CRM197 Market Size and Forecast (2018-2029)
       9.3.3 Argentina CRM197 Market Size and Forecast (2018-2029)

10 Middle East & Africa

   10.1 Middle East & Africa CRM197 Consumption Value by Type (2018-2029)
   10.2 Middle East & Africa CRM197 Consumption Value by Application (2018-2029)
   10.3 Middle East & Africa CRM197 Market Size by Country
       10.3.1 Middle East & Africa CRM197 Consumption Value by Country (2018-2029)
       10.3.2 Turkey CRM197 Market Size and Forecast (2018-2029)
       10.3.3 Saudi Arabia CRM197 Market Size and Forecast (2018-2029)
       10.3.4 UAE CRM197 Market Size and Forecast (2018-2029)

11 Market Dynamics

   11.1 CRM197 Market Drivers
   11.2 CRM197 Market Restraints
   11.3 CRM197 Trends Analysis
   11.4 Porters Five Forces Analysis
       11.4.1 Threat of New Entrants
       11.4.2 Bargaining Power of Suppliers
       11.4.3 Bargaining Power of Buyers
       11.4.4 Threat of Substitutes
       11.4.5 Competitive Rivalry
   11.5 Influence of COVID-19 and Russia-Ukraine War
       11.5.1 Influence of COVID-19
       11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

   12.1 CRM197 Industry Chain
   12.2 CRM197 Upstream Analysis
   12.3 CRM197 Midstream Analysis
   12.4 CRM197 Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

   14.1 Methodology
   14.2 Research Process and Data Source
   14.3 Disclaimer

List of Tables

   Table 1. Global CRM197 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global CRM197 Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Global CRM197 Consumption Value by Region (2018-2023) & (USD Million)
   Table 4. Global CRM197 Consumption Value by Region (2024-2029) & (USD Million)
   Table 5. Pfizer Inc. Company Information, Head Office, and Major Competitors
   Table 6. Pfizer Inc. Major Business
   Table 7. Pfizer Inc. CRM197 Product and Solutions
   Table 8. Pfizer Inc. CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 9. Pfizer Inc. Recent Developments and Future Plans
   Table 10. Ligand Pharmaceuticals Company Information, Head Office, and Major Competitors
   Table 11. Ligand Pharmaceuticals Major Business
   Table 12. Ligand Pharmaceuticals CRM197 Product and Solutions
   Table 13. Ligand Pharmaceuticals CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 14. Ligand Pharmaceuticals Recent Developments and Future Plans
   Table 15. CanSino Biologic Company Information, Head Office, and Major Competitors
   Table 16. CanSino Biologic Major Business
   Table 17. CanSino Biologic CRM197 Product and Solutions
   Table 18. CanSino Biologic CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 19. CanSino Biologic Recent Developments and Future Plans
   Table 20. Beijing Kexing Biology Product Company Information, Head Office, and Major Competitors
   Table 21. Beijing Kexing Biology Product Major Business
   Table 22. Beijing Kexing Biology Product CRM197 Product and Solutions
   Table 23. Beijing Kexing Biology Product CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 24. Beijing Kexing Biology Product Recent Developments and Future Plans
   Table 25. Scarab Genomics Company Information, Head Office, and Major Competitors
   Table 26. Scarab Genomics Major Business
   Table 27. Scarab Genomics CRM197 Product and Solutions
   Table 28. Scarab Genomics CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 29. Scarab Genomics Recent Developments and Future Plans
   Table 30. Xpress Biologics Company Information, Head Office, and Major Competitors
   Table 31. Xpress Biologics Major Business
   Table 32. Xpress Biologics CRM197 Product and Solutions
   Table 33. Xpress Biologics CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 34. Xpress Biologics Recent Developments and Future Plans
   Table 35. Fina Biosolutions Company Information, Head Office, and Major Competitors
   Table 36. Fina Biosolutions Major Business
   Table 37. Fina Biosolutions CRM197 Product and Solutions
   Table 38. Fina Biosolutions CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 39. Fina Biosolutions Recent Developments and Future Plans
   Table 40. Eubiologics Company Information, Head Office, and Major Competitors
   Table 41. Eubiologics Major Business
   Table 42. Eubiologics CRM197 Product and Solutions
   Table 43. Eubiologics CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 44. Eubiologics Recent Developments and Future Plans
   Table 45. EirGenix Inc. Company Information, Head Office, and Major Competitors
   Table 46. EirGenix Inc. Major Business
   Table 47. EirGenix Inc. CRM197 Product and Solutions
   Table 48. EirGenix Inc. CRM197 Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 49. EirGenix Inc. Recent Developments and Future Plans
   Table 50. Global CRM197 Revenue (USD Million) by Players (2018-2023)
   Table 51. Global CRM197 Revenue Share by Players (2018-2023)
   Table 52. Breakdown of CRM197 by Company Type (Tier 1, Tier 2, and Tier 3)
   Table 53. Market Position of Players in CRM197, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
   Table 54. Head Office of Key CRM197 Players
   Table 55. CRM197 Market: Company Product Type Footprint
   Table 56. CRM197 Market: Company Product Application Footprint
   Table 57. CRM197 New Market Entrants and Barriers to Market Entry
   Table 58. CRM197 Mergers, Acquisition, Agreements, and Collaborations
   Table 59. Global CRM197 Consumption Value (USD Million) by Type (2018-2023)
   Table 60. Global CRM197 Consumption Value Share by Type (2018-2023)
   Table 61. Global CRM197 Consumption Value Forecast by Type (2024-2029)
   Table 62. Global CRM197 Consumption Value by Application (2018-2023)
   Table 63. Global CRM197 Consumption Value Forecast by Application (2024-2029)
   Table 64. North America CRM197 Consumption Value by Type (2018-2023) & (USD Million)
   Table 65. North America CRM197 Consumption Value by Type (2024-2029) & (USD Million)
   Table 66. North America CRM197 Consumption Value by Application (2018-2023) & (USD Million)
   Table 67. North America CRM197 Consumption Value by Application (2024-2029) & (USD Million)
   Table 68. North America CRM197 Consumption Value by Country (2018-2023) & (USD Million)
   Table 69. North America CRM197 Consumption Value by Country (2024-2029) & (USD Million)
   Table 70. Europe CRM197 Consumption Value by Type (2018-2023) & (USD Million)
   Table 71. Europe CRM197 Consumption Value by Type (2024-2029) & (USD Million)
   Table 72. Europe CRM197 Consumption Value by Application (2018-2023) & (USD Million)
   Table 73. Europe CRM197 Consumption Value by Application (2024-2029) & (USD Million)
   Table 74. Europe CRM197 Consumption Value by Country (2018-2023) & (USD Million)
   Table 75. Europe CRM197 Consumption Value by Country (2024-2029) & (USD Million)
   Table 76. Asia-Pacific CRM197 Consumption Value by Type (2018-2023) & (USD Million)
   Table 77. Asia-Pacific CRM197 Consumption Value by Type (2024-2029) & (USD Million)
   Table 78. Asia-Pacific CRM197 Consumption Value by Application (2018-2023) & (USD Million)
   Table 79. Asia-Pacific CRM197 Consumption Value by Application (2024-2029) & (USD Million)
   Table 80. Asia-Pacific CRM197 Consumption Value by Region (2018-2023) & (USD Million)
   Table 81. Asia-Pacific CRM197 Consumption Value by Region (2024-2029) & (USD Million)
   Table 82. South America CRM197 Consumption Value by Type (2018-2023) & (USD Million)
   Table 83. South America CRM197 Consumption Value by Type (2024-2029) & (USD Million)
   Table 84. South America CRM197 Consumption Value by Application (2018-2023) & (USD Million)
   Table 85. South America CRM197 Consumption Value by Application (2024-2029) & (USD Million)
   Table 86. South America CRM197 Consumption Value by Country (2018-2023) & (USD Million)
   Table 87. South America CRM197 Consumption Value by Country (2024-2029) & (USD Million)
   Table 88. Middle East & Africa CRM197 Consumption Value by Type (2018-2023) & (USD Million)
   Table 89. Middle East & Africa CRM197 Consumption Value by Type (2024-2029) & (USD Million)
   Table 90. Middle East & Africa CRM197 Consumption Value by Application (2018-2023) & (USD Million)
   Table 91. Middle East & Africa CRM197 Consumption Value by Application (2024-2029) & (USD Million)
   Table 92. Middle East & Africa CRM197 Consumption Value by Country (2018-2023) & (USD Million)
   Table 93. Middle East & Africa CRM197 Consumption Value by Country (2024-2029) & (USD Million)
   Table 94. CRM197 Raw Material
   Table 95. Key Suppliers of CRM197 Raw Materials

List of Figures

   Figure 1. CRM197 Picture
   Figure 2. Global CRM197 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global CRM197 Consumption Value Market Share by Type in 2022
   Figure 4. Research Grade CRM197
   Figure 5. cGMP Grade CRM197
   Figure 6. Global CRM197 Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 7. CRM197 Consumption Value Market Share by Application in 2022
   Figure 8. Pneumococcal Conjugate Vaccine Picture
   Figure 9. Meningococcal Polysaccharide Conjugate Vaccine Picture
   Figure 10. Others Picture
   Figure 11. Global CRM197 Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 12. Global CRM197 Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 13. Global Market CRM197 Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
   Figure 14. Global CRM197 Consumption Value Market Share by Region (2018-2029)
   Figure 15. Global CRM197 Consumption Value Market Share by Region in 2022
   Figure 16. North America CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 17. Europe CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 18. Asia-Pacific CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 19. South America CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 20. Middle East and Africa CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 21. Global CRM197 Revenue Share by Players in 2022
   Figure 22. CRM197 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
   Figure 23. Global Top 3 Players CRM197 Market Share in 2022
   Figure 24. Global Top 6 Players CRM197 Market Share in 2022
   Figure 25. Global CRM197 Consumption Value Share by Type (2018-2023)
   Figure 26. Global CRM197 Market Share Forecast by Type (2024-2029)
   Figure 27. Global CRM197 Consumption Value Share by Application (2018-2023)
   Figure 28. Global CRM197 Market Share Forecast by Application (2024-2029)
   Figure 29. North America CRM197 Consumption Value Market Share by Type (2018-2029)
   Figure 30. North America CRM197 Consumption Value Market Share by Application (2018-2029)
   Figure 31. North America CRM197 Consumption Value Market Share by Country (2018-2029)
   Figure 32. United States CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 33. Canada CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 34. Mexico CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 35. Europe CRM197 Consumption Value Market Share by Type (2018-2029)
   Figure 36. Europe CRM197 Consumption Value Market Share by Application (2018-2029)
   Figure 37. Europe CRM197 Consumption Value Market Share by Country (2018-2029)
   Figure 38. Germany CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 39. France CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 40. United Kingdom CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 41. Russia CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 42. Italy CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 43. Asia-Pacific CRM197 Consumption Value Market Share by Type (2018-2029)
   Figure 44. Asia-Pacific CRM197 Consumption Value Market Share by Application (2018-2029)
   Figure 45. Asia-Pacific CRM197 Consumption Value Market Share by Region (2018-2029)
   Figure 46. China CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 47. Japan CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 48. South Korea CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 49. India CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 50. Southeast Asia CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 51. Australia CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 52. South America CRM197 Consumption Value Market Share by Type (2018-2029)
   Figure 53. South America CRM197 Consumption Value Market Share by Application (2018-2029)
   Figure 54. South America CRM197 Consumption Value Market Share by Country (2018-2029)
   Figure 55. Brazil CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 56. Argentina CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 57. Middle East and Africa CRM197 Consumption Value Market Share by Type (2018-2029)
   Figure 58. Middle East and Africa CRM197 Consumption Value Market Share by Application (2018-2029)
   Figure 59. Middle East and Africa CRM197 Consumption Value Market Share by Country (2018-2029)
   Figure 60. Turkey CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 61. Saudi Arabia CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 62. UAE CRM197 Consumption Value (2018-2029) & (USD Million)
   Figure 63. CRM197 Market Drivers
   Figure 64. CRM197 Market Restraints
   Figure 65. CRM197 Market Trends
   Figure 66. Porters Five Forces Analysis
   Figure 67. Manufacturing Cost Structure Analysis of CRM197 in 2022
   Figure 68. Manufacturing Process Analysis of CRM197
   Figure 69. CRM197 Industrial Chain
   Figure 70. Methodology
   Figure 71. Research Process and Data Source